nodes	percent_of_prediction	percent_of_DWPC	metapath
Droperidol—HTR2A—epilepsy syndrome	0.433	1	CbGaD
Droperidol—HTR2A—phrenic nerve—epilepsy syndrome	0.0177	0.171	CbGeAlD
Droperidol—HTR2A—locus ceruleus—epilepsy syndrome	0.0079	0.0762	CbGeAlD
Droperidol—HTR2A—cerebellar cortex—epilepsy syndrome	0.00644	0.0621	CbGeAlD
Droperidol—HTR2A—vagus nerve—epilepsy syndrome	0.00605	0.0583	CbGeAlD
Droperidol—DRD2—telencephalic ventricle—epilepsy syndrome	0.00568	0.0548	CbGeAlD
Droperidol—HTR2A—pons—epilepsy syndrome	0.00455	0.0439	CbGeAlD
Droperidol—HTR2A—autonomic nervous system—epilepsy syndrome	0.0042	0.0405	CbGeAlD
Droperidol—HTR2A—telencephalic ventricle—epilepsy syndrome	0.00375	0.0361	CbGeAlD
Droperidol—DRD2—ganglion—epilepsy syndrome	0.00353	0.0341	CbGeAlD
Droperidol—ADRA1A—hindbrain—epilepsy syndrome	0.00273	0.0264	CbGeAlD
Droperidol—DRD2—hindbrain—epilepsy syndrome	0.00268	0.0259	CbGeAlD
Droperidol—HTR2A—ganglion—epilepsy syndrome	0.00233	0.0225	CbGeAlD
Droperidol—HTR2A—hindbrain—epilepsy syndrome	0.00177	0.0171	CbGeAlD
Droperidol—ADRA1A—brainstem—epilepsy syndrome	0.00157	0.0151	CbGeAlD
Droperidol—DRD2—brainstem—epilepsy syndrome	0.00154	0.0148	CbGeAlD
Droperidol—ADRA1A—forebrain—epilepsy syndrome	0.00151	0.0146	CbGeAlD
Droperidol—DRD2—forebrain—epilepsy syndrome	0.00148	0.0143	CbGeAlD
Droperidol—KCNH2—forebrain—epilepsy syndrome	0.00146	0.0141	CbGeAlD
Droperidol—Pimozide—CACNA1G—epilepsy syndrome	0.00143	0.188	CrCbGaD
Droperidol—ADRA1A—telencephalon—epilepsy syndrome	0.00139	0.0134	CbGeAlD
Droperidol—DRD2—telencephalon—epilepsy syndrome	0.00136	0.0131	CbGeAlD
Droperidol—KCNH2—telencephalon—epilepsy syndrome	0.00134	0.013	CbGeAlD
Droperidol—KCNH2—medulla oblongata—epilepsy syndrome	0.00106	0.0102	CbGeAlD
Droperidol—HTR2A—brainstem—epilepsy syndrome	0.00101	0.00977	CbGeAlD
Droperidol—DRD2—midbrain—epilepsy syndrome	0.000979	0.00944	CbGeAlD
Droperidol—HTR2A—forebrain—epilepsy syndrome	0.000978	0.00943	CbGeAlD
Droperidol—KCNH2—midbrain—epilepsy syndrome	0.000965	0.0093	CbGeAlD
Droperidol—KCNH2—spinal cord—epilepsy syndrome	0.000941	0.00908	CbGeAlD
Droperidol—HTR2A—telencephalon—epilepsy syndrome	0.000899	0.00867	CbGeAlD
Droperidol—Haloperidol—GRIN2B—epilepsy syndrome	0.00088	0.115	CrCbGaD
Droperidol—ADRA1A—head—epilepsy syndrome	0.000866	0.00835	CbGeAlD
Droperidol—DRD2—head—epilepsy syndrome	0.000849	0.00819	CbGeAlD
Droperidol—KCNH2—head—epilepsy syndrome	0.000837	0.00807	CbGeAlD
Droperidol—ADRA1A—nervous system—epilepsy syndrome	0.000821	0.00792	CbGeAlD
Droperidol—DRD2—nervous system—epilepsy syndrome	0.000805	0.00776	CbGeAlD
Droperidol—KCNH2—nervous system—epilepsy syndrome	0.000793	0.00765	CbGeAlD
Droperidol—ADRA1A—central nervous system—epilepsy syndrome	0.000791	0.00762	CbGeAlD
Droperidol—DRD2—central nervous system—epilepsy syndrome	0.000775	0.00747	CbGeAlD
Droperidol—ADRA1A—cerebellum—epilepsy syndrome	0.000773	0.00745	CbGeAlD
Droperidol—KCNH2—central nervous system—epilepsy syndrome	0.000764	0.00736	CbGeAlD
Droperidol—DRD2—cerebellum—epilepsy syndrome	0.000757	0.0073	CbGeAlD
Droperidol—KCNH2—cerebellum—epilepsy syndrome	0.000746	0.0072	CbGeAlD
Droperidol—HTR2A—medulla oblongata—epilepsy syndrome	0.000707	0.00681	CbGeAlD
Droperidol—HTR2A—midbrain—epilepsy syndrome	0.000646	0.00623	CbGeAlD
Droperidol—HTR2A—spinal cord—epilepsy syndrome	0.00063	0.00608	CbGeAlD
Droperidol—ADRA1A—brain—epilepsy syndrome	0.000628	0.00605	CbGeAlD
Droperidol—Pimozide—OPRM1—epilepsy syndrome	0.000618	0.0808	CrCbGaD
Droperidol—DRD2—brain—epilepsy syndrome	0.000615	0.00593	CbGeAlD
Droperidol—KCNH2—brain—epilepsy syndrome	0.000606	0.00585	CbGeAlD
Droperidol—Fluspirilene—ADRA2A—epilepsy syndrome	0.000597	0.0781	CrCbGaD
Droperidol—HTR2A—head—epilepsy syndrome	0.00056	0.0054	CbGeAlD
Droperidol—HTR2A—nervous system—epilepsy syndrome	0.000531	0.00512	CbGeAlD
Droperidol—Pimozide—CHRM2—epilepsy syndrome	0.000523	0.0684	CrCbGaD
Droperidol—HTR2A—central nervous system—epilepsy syndrome	0.000511	0.00493	CbGeAlD
Droperidol—HTR2A—cerebellum—epilepsy syndrome	0.0005	0.00482	CbGeAlD
Droperidol—Hypersensitivity—Phenobarbital—epilepsy syndrome	0.000496	0.00175	CcSEcCtD
Droperidol—Hypertension—Fosphenytoin—epilepsy syndrome	0.000492	0.00173	CcSEcCtD
Droperidol—Body temperature increased—Lacosamide—epilepsy syndrome	0.000491	0.00173	CcSEcCtD
Droperidol—Shock—Propofol—epilepsy syndrome	0.000491	0.00173	CcSEcCtD
Droperidol—Syncope—Diazepam—epilepsy syndrome	0.00049	0.00172	CcSEcCtD
Droperidol—Anaphylactic shock—Midazolam—epilepsy syndrome	0.000488	0.00172	CcSEcCtD
Droperidol—Chills—Carbamazepine—epilepsy syndrome	0.000488	0.00172	CcSEcCtD
Droperidol—Hypersensitivity—Rufinamide—epilepsy syndrome	0.000487	0.00171	CcSEcCtD
Droperidol—Tachycardia—Propofol—epilepsy syndrome	0.000487	0.00171	CcSEcCtD
Droperidol—Palpitations—Diazepam—epilepsy syndrome	0.000483	0.0017	CcSEcCtD
Droperidol—Loss of consciousness—Diazepam—epilepsy syndrome	0.00048	0.00169	CcSEcCtD
Droperidol—Shock—Midazolam—epilepsy syndrome	0.00048	0.00169	CcSEcCtD
Droperidol—Rash—Trimethadione—epilepsy syndrome	0.000479	0.00169	CcSEcCtD
Droperidol—Dermatitis—Trimethadione—epilepsy syndrome	0.000479	0.00168	CcSEcCtD
Droperidol—Somnolence—Acetazolamide—epilepsy syndrome	0.000477	0.00168	CcSEcCtD
Droperidol—Body temperature increased—Clobazam—epilepsy syndrome	0.000476	0.00167	CcSEcCtD
Droperidol—Tachycardia—Midazolam—epilepsy syndrome	0.000476	0.00167	CcSEcCtD
Droperidol—Cardiac arrest—Gabapentin—epilepsy syndrome	0.000476	0.00167	CcSEcCtD
Droperidol—Chills—Lamotrigine—epilepsy syndrome	0.000471	0.00166	CcSEcCtD
Droperidol—Anxiety—Vigabatrin—epilepsy syndrome	0.000471	0.00166	CcSEcCtD
Droperidol—Palpitations—Felbamate—epilepsy syndrome	0.000468	0.00164	CcSEcCtD
Droperidol—Hypotension—Propofol—epilepsy syndrome	0.000466	0.00164	CcSEcCtD
Droperidol—Drowsiness—Valproic Acid—epilepsy syndrome	0.000465	0.00164	CcSEcCtD
Droperidol—Anaphylactic shock—Fosphenytoin—epilepsy syndrome	0.000465	0.00164	CcSEcCtD
Droperidol—Syncope—Zonisamide—epilepsy syndrome	0.000464	0.00163	CcSEcCtD
Droperidol—Depression—Valproic Acid—epilepsy syndrome	0.000464	0.00163	CcSEcCtD
Droperidol—Palpitations—Zonisamide—epilepsy syndrome	0.000458	0.00161	CcSEcCtD
Droperidol—Shock—Fosphenytoin—epilepsy syndrome	0.000457	0.00161	CcSEcCtD
Droperidol—Hypersensitivity—Lacosamide—epilepsy syndrome	0.000457	0.00161	CcSEcCtD
Droperidol—Hypertension—Felbamate—epilepsy syndrome	0.000457	0.00161	CcSEcCtD
Droperidol—Angioedema—Clonazepam—epilepsy syndrome	0.000456	0.0016	CcSEcCtD
Droperidol—Hypotension—Midazolam—epilepsy syndrome	0.000456	0.0016	CcSEcCtD
Droperidol—Fluspirilene—SLC6A4—epilepsy syndrome	0.000456	0.0596	CrCbGaD
Droperidol—Loss of consciousness—Zonisamide—epilepsy syndrome	0.000455	0.0016	CcSEcCtD
Droperidol—Tachycardia—Fosphenytoin—epilepsy syndrome	0.000454	0.0016	CcSEcCtD
Droperidol—Angioedema—Oxcarbazepine—epilepsy syndrome	0.000451	0.00159	CcSEcCtD
Droperidol—Anxiety—Felbamate—epilepsy syndrome	0.000449	0.00158	CcSEcCtD
Droperidol—Hypertension—Zonisamide—epilepsy syndrome	0.000447	0.00157	CcSEcCtD
Droperidol—Anaphylactic shock—Diazepam—epilepsy syndrome	0.000446	0.00157	CcSEcCtD
Droperidol—Dizziness—Phenobarbital—epilepsy syndrome	0.000445	0.00157	CcSEcCtD
Droperidol—Syncope—Phenytoin—epilepsy syndrome	0.000445	0.00156	CcSEcCtD
Droperidol—Somnolence—Propofol—epilepsy syndrome	0.000443	0.00156	CcSEcCtD
Droperidol—Syncope—Oxcarbazepine—epilepsy syndrome	0.000442	0.00156	CcSEcCtD
Droperidol—Palpitations—Clonazepam—epilepsy syndrome	0.000441	0.00155	CcSEcCtD
Droperidol—Anxiety—Zonisamide—epilepsy syndrome	0.000439	0.00155	CcSEcCtD
Droperidol—Shock—Diazepam—epilepsy syndrome	0.000439	0.00154	CcSEcCtD
Droperidol—Palpitations—Phenytoin—epilepsy syndrome	0.000438	0.00154	CcSEcCtD
Droperidol—Dizziness—Rufinamide—epilepsy syndrome	0.000437	0.00154	CcSEcCtD
Droperidol—Palpitations—Oxcarbazepine—epilepsy syndrome	0.000436	0.00153	CcSEcCtD
Droperidol—Loss of consciousness—Phenytoin—epilepsy syndrome	0.000436	0.00153	CcSEcCtD
Droperidol—Tachycardia—Diazepam—epilepsy syndrome	0.000435	0.00153	CcSEcCtD
Droperidol—Hypotension—Fosphenytoin—epilepsy syndrome	0.000434	0.00153	CcSEcCtD
Droperidol—Somnolence—Midazolam—epilepsy syndrome	0.000434	0.00153	CcSEcCtD
Droperidol—Loss of consciousness—Oxcarbazepine—epilepsy syndrome	0.000433	0.00152	CcSEcCtD
Droperidol—Angioedema—Carbamazepine—epilepsy syndrome	0.000432	0.00152	CcSEcCtD
Droperidol—Anaphylactic shock—Felbamate—epilepsy syndrome	0.000432	0.00152	CcSEcCtD
Droperidol—Somnolence—Levetiracetam—epilepsy syndrome	0.000428	0.00151	CcSEcCtD
Droperidol—Hypertension—Phenytoin—epilepsy syndrome	0.000428	0.00151	CcSEcCtD
Droperidol—Hypertension—Oxcarbazepine—epilepsy syndrome	0.000426	0.0015	CcSEcCtD
Droperidol—Hyperglycaemia—Pregabalin—epilepsy syndrome	0.000425	0.0015	CcSEcCtD
Droperidol—Bronchospasm—Gabapentin—epilepsy syndrome	0.000425	0.0015	CcSEcCtD
Droperidol—Rash—Phenobarbital—epilepsy syndrome	0.000425	0.00149	CcSEcCtD
Droperidol—Syncope—Carbamazepine—epilepsy syndrome	0.000424	0.00149	CcSEcCtD
Droperidol—Body temperature increased—Acetazolamide—epilepsy syndrome	0.000424	0.00149	CcSEcCtD
Droperidol—Dermatitis—Phenobarbital—epilepsy syndrome	0.000424	0.00149	CcSEcCtD
Droperidol—Anxiety—Clonazepam—epilepsy syndrome	0.000423	0.00149	CcSEcCtD
Droperidol—Tachycardia—Felbamate—epilepsy syndrome	0.000421	0.00148	CcSEcCtD
Droperidol—Depression—Pregabalin—epilepsy syndrome	0.000419	0.00147	CcSEcCtD
Droperidol—Anxiety—Oxcarbazepine—epilepsy syndrome	0.000418	0.00147	CcSEcCtD
Droperidol—Angioedema—Lamotrigine—epilepsy syndrome	0.000418	0.00147	CcSEcCtD
Droperidol—Hypotension—Diazepam—epilepsy syndrome	0.000417	0.00147	CcSEcCtD
Droperidol—Rash—Rufinamide—epilepsy syndrome	0.000417	0.00147	CcSEcCtD
Droperidol—Dermatitis—Rufinamide—epilepsy syndrome	0.000416	0.00146	CcSEcCtD
Droperidol—Loss of consciousness—Carbamazepine—epilepsy syndrome	0.000416	0.00146	CcSEcCtD
Droperidol—Shock—Zonisamide—epilepsy syndrome	0.000416	0.00146	CcSEcCtD
Droperidol—Hallucination—Valproic Acid—epilepsy syndrome	0.000415	0.00146	CcSEcCtD
Droperidol—Somnolence—Fosphenytoin—epilepsy syndrome	0.000413	0.00145	CcSEcCtD
Droperidol—Tachycardia—Zonisamide—epilepsy syndrome	0.000413	0.00145	CcSEcCtD
Droperidol—Dizziness—Lacosamide—epilepsy syndrome	0.00041	0.00144	CcSEcCtD
Droperidol—Syncope—Lamotrigine—epilepsy syndrome	0.00041	0.00144	CcSEcCtD
Droperidol—Hypertension—Carbamazepine—epilepsy syndrome	0.000409	0.00144	CcSEcCtD
Droperidol—Anaphylactic shock—Clonazepam—epilepsy syndrome	0.000407	0.00143	CcSEcCtD
Droperidol—HTR2A—brain—epilepsy syndrome	0.000406	0.00391	CbGeAlD
Droperidol—Anaphylactic shock—Phenytoin—epilepsy syndrome	0.000405	0.00142	CcSEcCtD
Droperidol—Palpitations—Lamotrigine—epilepsy syndrome	0.000404	0.00142	CcSEcCtD
Droperidol—Hypotension—Felbamate—epilepsy syndrome	0.000403	0.00142	CcSEcCtD
Droperidol—Somnolence—Vigabatrin—epilepsy syndrome	0.000403	0.00142	CcSEcCtD
Droperidol—Anaphylactic shock—Oxcarbazepine—epilepsy syndrome	0.000402	0.00142	CcSEcCtD
Droperidol—Loss of consciousness—Lamotrigine—epilepsy syndrome	0.000402	0.00141	CcSEcCtD
Droperidol—Anxiety—Carbamazepine—epilepsy syndrome	0.000402	0.00141	CcSEcCtD
Droperidol—Dizziness—Clobazam—epilepsy syndrome	0.000398	0.0014	CcSEcCtD
Droperidol—Shock—Phenytoin—epilepsy syndrome	0.000398	0.0014	CcSEcCtD
Droperidol—Tachycardia—Clonazepam—epilepsy syndrome	0.000398	0.0014	CcSEcCtD
Droperidol—Somnolence—Diazepam—epilepsy syndrome	0.000397	0.0014	CcSEcCtD
Droperidol—Fenbufen—PTGS2—epilepsy syndrome	0.000396	0.0518	CrCbGaD
Droperidol—Shock—Oxcarbazepine—epilepsy syndrome	0.000396	0.00139	CcSEcCtD
Droperidol—Hypotension—Zonisamide—epilepsy syndrome	0.000395	0.00139	CcSEcCtD
Droperidol—Tachycardia—Phenytoin—epilepsy syndrome	0.000395	0.00139	CcSEcCtD
Droperidol—Hypertension—Lamotrigine—epilepsy syndrome	0.000395	0.00139	CcSEcCtD
Droperidol—Body temperature increased—Propofol—epilepsy syndrome	0.000394	0.00139	CcSEcCtD
Droperidol—Tachycardia—Oxcarbazepine—epilepsy syndrome	0.000393	0.00138	CcSEcCtD
Droperidol—Rash—Lacosamide—epilepsy syndrome	0.000391	0.00138	CcSEcCtD
Droperidol—Dermatitis—Lacosamide—epilepsy syndrome	0.000391	0.00138	CcSEcCtD
Droperidol—Hyperglycaemia—Gabapentin—epilepsy syndrome	0.00039	0.00137	CcSEcCtD
Droperidol—Anxiety—Lamotrigine—epilepsy syndrome	0.000388	0.00137	CcSEcCtD
Droperidol—Anaphylactic shock—Carbamazepine—epilepsy syndrome	0.000386	0.00136	CcSEcCtD
Droperidol—Drowsiness—Gabapentin—epilepsy syndrome	0.000386	0.00136	CcSEcCtD
Droperidol—Depression—Gabapentin—epilepsy syndrome	0.000384	0.00135	CcSEcCtD
Droperidol—Somnolence—Felbamate—epilepsy syndrome	0.000384	0.00135	CcSEcCtD
Droperidol—Body temperature increased—Levetiracetam—epilepsy syndrome	0.000381	0.00134	CcSEcCtD
Droperidol—Hypotension—Clonazepam—epilepsy syndrome	0.000381	0.00134	CcSEcCtD
Droperidol—Shock—Carbamazepine—epilepsy syndrome	0.00038	0.00134	CcSEcCtD
Droperidol—Rash—Clobazam—epilepsy syndrome	0.00038	0.00134	CcSEcCtD
Droperidol—Dermatitis—Clobazam—epilepsy syndrome	0.000379	0.00133	CcSEcCtD
Droperidol—Hypotension—Phenytoin—epilepsy syndrome	0.000378	0.00133	CcSEcCtD
Droperidol—Tachycardia—Carbamazepine—epilepsy syndrome	0.000377	0.00133	CcSEcCtD
Droperidol—Hypotension—Oxcarbazepine—epilepsy syndrome	0.000376	0.00132	CcSEcCtD
Droperidol—Somnolence—Zonisamide—epilepsy syndrome	0.000376	0.00132	CcSEcCtD
Droperidol—Hallucination—Pregabalin—epilepsy syndrome	0.000376	0.00132	CcSEcCtD
Droperidol—Chills—Valproic Acid—epilepsy syndrome	0.000375	0.00132	CcSEcCtD
Droperidol—Body temperature increased—Fosphenytoin—epilepsy syndrome	0.000368	0.00129	CcSEcCtD
Droperidol—Shock—Lamotrigine—epilepsy syndrome	0.000367	0.00129	CcSEcCtD
Droperidol—Tachycardia—Lamotrigine—epilepsy syndrome	0.000364	0.00128	CcSEcCtD
Droperidol—Somnolence—Clonazepam—epilepsy syndrome	0.000362	0.00127	CcSEcCtD
Droperidol—Hypotension—Carbamazepine—epilepsy syndrome	0.000361	0.00127	CcSEcCtD
Droperidol—Somnolence—Phenytoin—epilepsy syndrome	0.00036	0.00127	CcSEcCtD
Droperidol—Hypersensitivity—Midazolam—epilepsy syndrome	0.000359	0.00126	CcSEcCtD
Droperidol—Body temperature increased—Vigabatrin—epilepsy syndrome	0.000358	0.00126	CcSEcCtD
Droperidol—Somnolence—Oxcarbazepine—epilepsy syndrome	0.000358	0.00126	CcSEcCtD
Droperidol—Dizziness—Acetazolamide—epilepsy syndrome	0.000355	0.00125	CcSEcCtD
Droperidol—Hypersensitivity—Levetiracetam—epilepsy syndrome	0.000355	0.00125	CcSEcCtD
Droperidol—Fluspirilene—HTR2A—epilepsy syndrome	0.00035	0.0458	CrCbGaD
Droperidol—Hallucination—Gabapentin—epilepsy syndrome	0.000344	0.00121	CcSEcCtD
Droperidol—Somnolence—Carbamazepine—epilepsy syndrome	0.000343	0.00121	CcSEcCtD
Droperidol—Body temperature increased—Felbamate—epilepsy syndrome	0.000341	0.0012	CcSEcCtD
Droperidol—Chills—Pregabalin—epilepsy syndrome	0.000339	0.00119	CcSEcCtD
Droperidol—Body temperature increased—Zonisamide—epilepsy syndrome	0.000334	0.00118	CcSEcCtD
Droperidol—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.000334	0.00117	CcSEcCtD
Droperidol—Angioedema—Valproic Acid—epilepsy syndrome	0.000332	0.00117	CcSEcCtD
Droperidol—Somnolence—Lamotrigine—epilepsy syndrome	0.000332	0.00117	CcSEcCtD
Droperidol—Dizziness—Propofol—epilepsy syndrome	0.00033	0.00116	CcSEcCtD
Droperidol—Hypersensitivity—Diazepam—epilepsy syndrome	0.000329	0.00116	CcSEcCtD
Droperidol—Hyperglycaemia—Topiramate—epilepsy syndrome	0.000328	0.00115	CcSEcCtD
Droperidol—Depression—Topiramate—epilepsy syndrome	0.000323	0.00114	CcSEcCtD
Droperidol—Pimozide—CYP2C19—epilepsy syndrome	0.000323	0.0422	CrCbGaD
Droperidol—Dizziness—Midazolam—epilepsy syndrome	0.000323	0.00113	CcSEcCtD
Droperidol—Body temperature increased—Clonazepam—epilepsy syndrome	0.000322	0.00113	CcSEcCtD
Droperidol—Palpitations—Valproic Acid—epilepsy syndrome	0.000321	0.00113	CcSEcCtD
Droperidol—Body temperature increased—Phenytoin—epilepsy syndrome	0.00032	0.00113	CcSEcCtD
Droperidol—Dizziness—Levetiracetam—epilepsy syndrome	0.000319	0.00112	CcSEcCtD
Droperidol—Body temperature increased—Oxcarbazepine—epilepsy syndrome	0.000318	0.00112	CcSEcCtD
Droperidol—Rash—Propofol—epilepsy syndrome	0.000314	0.00111	CcSEcCtD
Droperidol—Dermatitis—Propofol—epilepsy syndrome	0.000314	0.0011	CcSEcCtD
Droperidol—Hypertension—Valproic Acid—epilepsy syndrome	0.000314	0.0011	CcSEcCtD
Droperidol—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000311	0.0011	CcSEcCtD
Droperidol—Chills—Gabapentin—epilepsy syndrome	0.000311	0.00109	CcSEcCtD
Droperidol—Anxiety—Valproic Acid—epilepsy syndrome	0.000308	0.00108	CcSEcCtD
Droperidol—Rash—Midazolam—epilepsy syndrome	0.000308	0.00108	CcSEcCtD
Droperidol—Dizziness—Fosphenytoin—epilepsy syndrome	0.000307	0.00108	CcSEcCtD
Droperidol—Dermatitis—Midazolam—epilepsy syndrome	0.000307	0.00108	CcSEcCtD
Droperidol—Body temperature increased—Carbamazepine—epilepsy syndrome	0.000305	0.00107	CcSEcCtD
Droperidol—Rash—Levetiracetam—epilepsy syndrome	0.000304	0.00107	CcSEcCtD
Droperidol—Dermatitis—Levetiracetam—epilepsy syndrome	0.000303	0.00107	CcSEcCtD
Droperidol—Angioedema—Pregabalin—epilepsy syndrome	0.0003	0.00106	CcSEcCtD
Droperidol—Hypersensitivity—Clonazepam—epilepsy syndrome	0.0003	0.00106	CcSEcCtD
Droperidol—Dizziness—Vigabatrin—epilepsy syndrome	0.0003	0.00105	CcSEcCtD
Droperidol—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000298	0.00105	CcSEcCtD
Droperidol—Anaphylactic shock—Valproic Acid—epilepsy syndrome	0.000297	0.00104	CcSEcCtD
Droperidol—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000297	0.00104	CcSEcCtD
Droperidol—Body temperature increased—Lamotrigine—epilepsy syndrome	0.000295	0.00104	CcSEcCtD
Droperidol—Dizziness—Diazepam—epilepsy syndrome	0.000295	0.00104	CcSEcCtD
Droperidol—Haloperidol—CYP2C19—epilepsy syndrome	0.000295	0.0385	CrCbGaD
Droperidol—Syncope—Pregabalin—epilepsy syndrome	0.000295	0.00104	CcSEcCtD
Droperidol—Rash—Fosphenytoin—epilepsy syndrome	0.000293	0.00103	CcSEcCtD
Droperidol—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000293	0.00103	CcSEcCtD
Droperidol—Palpitations—Pregabalin—epilepsy syndrome	0.00029	0.00102	CcSEcCtD
Droperidol—Hallucination—Topiramate—epilepsy syndrome	0.00029	0.00102	CcSEcCtD
Droperidol—Tachycardia—Valproic Acid—epilepsy syndrome	0.00029	0.00102	CcSEcCtD
Droperidol—Loss of consciousness—Pregabalin—epilepsy syndrome	0.000289	0.00102	CcSEcCtD
Droperidol—Domperidone—CYP2D6—epilepsy syndrome	0.000287	0.0375	CrCbGaD
Droperidol—Rash—Vigabatrin—epilepsy syndrome	0.000286	0.00101	CcSEcCtD
Droperidol—Dizziness—Felbamate—epilepsy syndrome	0.000286	0.001	CcSEcCtD
Droperidol—Dermatitis—Vigabatrin—epilepsy syndrome	0.000285	0.001	CcSEcCtD
Droperidol—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000285	0.001	CcSEcCtD
Droperidol—Hypertension—Pregabalin—epilepsy syndrome	0.000284	0.000998	CcSEcCtD
Droperidol—Rash—Diazepam—epilepsy syndrome	0.000281	0.00099	CcSEcCtD
Droperidol—Dermatitis—Diazepam—epilepsy syndrome	0.000281	0.000989	CcSEcCtD
Droperidol—Dizziness—Zonisamide—epilepsy syndrome	0.00028	0.000983	CcSEcCtD
Droperidol—Anxiety—Pregabalin—epilepsy syndrome	0.000279	0.000981	CcSEcCtD
Droperidol—Hypotension—Valproic Acid—epilepsy syndrome	0.000277	0.000975	CcSEcCtD
Droperidol—Angioedema—Gabapentin—epilepsy syndrome	0.000275	0.000969	CcSEcCtD
Droperidol—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000275	0.000968	CcSEcCtD
Droperidol—Rash—Felbamate—epilepsy syndrome	0.000272	0.000958	CcSEcCtD
Droperidol—Dermatitis—Felbamate—epilepsy syndrome	0.000272	0.000957	CcSEcCtD
Droperidol—Syncope—Gabapentin—epilepsy syndrome	0.00027	0.000951	CcSEcCtD
Droperidol—Dizziness—Clonazepam—epilepsy syndrome	0.000269	0.000948	CcSEcCtD
Droperidol—Anaphylactic shock—Pregabalin—epilepsy syndrome	0.000268	0.000943	CcSEcCtD
Droperidol—Dizziness—Phenytoin—epilepsy syndrome	0.000268	0.000941	CcSEcCtD
Droperidol—Rash—Zonisamide—epilepsy syndrome	0.000267	0.000938	CcSEcCtD
Droperidol—Palpitations—Gabapentin—epilepsy syndrome	0.000266	0.000937	CcSEcCtD
Droperidol—Dermatitis—Zonisamide—epilepsy syndrome	0.000266	0.000937	CcSEcCtD
Droperidol—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000266	0.000936	CcSEcCtD
Droperidol—Loss of consciousness—Gabapentin—epilepsy syndrome	0.000265	0.000932	CcSEcCtD
Droperidol—Shock—Pregabalin—epilepsy syndrome	0.000264	0.000928	CcSEcCtD
Droperidol—Somnolence—Valproic Acid—epilepsy syndrome	0.000264	0.000928	CcSEcCtD
Droperidol—Pimozide—HTR2A—epilepsy syndrome	0.000262	0.0342	CrCbGaD
Droperidol—Tachycardia—Pregabalin—epilepsy syndrome	0.000262	0.000921	CcSEcCtD
Droperidol—Chills—Topiramate—epilepsy syndrome	0.000261	0.000919	CcSEcCtD
Droperidol—Hypertension—Gabapentin—epilepsy syndrome	0.00026	0.000915	CcSEcCtD
Droperidol—Rash—Clonazepam—epilepsy syndrome	0.000257	0.000904	CcSEcCtD
Droperidol—Dermatitis—Clonazepam—epilepsy syndrome	0.000257	0.000903	CcSEcCtD
Droperidol—Anxiety—Gabapentin—epilepsy syndrome	0.000256	0.000899	CcSEcCtD
Droperidol—Dizziness—Carbamazepine—epilepsy syndrome	0.000255	0.000899	CcSEcCtD
Droperidol—Rash—Phenytoin—epilepsy syndrome	0.000255	0.000898	CcSEcCtD
Droperidol—Dermatitis—Phenytoin—epilepsy syndrome	0.000255	0.000897	CcSEcCtD
Droperidol—Rash—Oxcarbazepine—epilepsy syndrome	0.000254	0.000893	CcSEcCtD
Droperidol—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000254	0.000892	CcSEcCtD
Droperidol—Hypotension—Pregabalin—epilepsy syndrome	0.000251	0.000882	CcSEcCtD
Droperidol—Dizziness—Lamotrigine—epilepsy syndrome	0.000247	0.000868	CcSEcCtD
Droperidol—Anaphylactic shock—Gabapentin—epilepsy syndrome	0.000246	0.000865	CcSEcCtD
Droperidol—Rash—Carbamazepine—epilepsy syndrome	0.000244	0.000857	CcSEcCtD
Droperidol—Dermatitis—Carbamazepine—epilepsy syndrome	0.000243	0.000856	CcSEcCtD
Droperidol—Shock—Gabapentin—epilepsy syndrome	0.000242	0.000851	CcSEcCtD
Droperidol—Tachycardia—Gabapentin—epilepsy syndrome	0.00024	0.000844	CcSEcCtD
Droperidol—Pimozide—CYP2D6—epilepsy syndrome	0.000239	0.0313	CrCbGaD
Droperidol—Haloperidol—HTR2A—epilepsy syndrome	0.000239	0.0312	CrCbGaD
Droperidol—Somnolence—Pregabalin—epilepsy syndrome	0.000238	0.000839	CcSEcCtD
Droperidol—Rash—Lamotrigine—epilepsy syndrome	0.000235	0.000828	CcSEcCtD
Droperidol—Dermatitis—Lamotrigine—epilepsy syndrome	0.000235	0.000827	CcSEcCtD
Droperidol—Body temperature increased—Valproic Acid—epilepsy syndrome	0.000234	0.000825	CcSEcCtD
Droperidol—Hypotension—Gabapentin—epilepsy syndrome	0.00023	0.000808	CcSEcCtD
Droperidol—Syncope—Topiramate—epilepsy syndrome	0.000227	0.0008	CcSEcCtD
Droperidol—Palpitations—Topiramate—epilepsy syndrome	0.000224	0.000788	CcSEcCtD
Droperidol—Loss of consciousness—Topiramate—epilepsy syndrome	0.000223	0.000784	CcSEcCtD
Droperidol—Hypertension—Topiramate—epilepsy syndrome	0.000219	0.00077	CcSEcCtD
Droperidol—Somnolence—Gabapentin—epilepsy syndrome	0.000219	0.000769	CcSEcCtD
Droperidol—Haloperidol—CYP2D6—epilepsy syndrome	0.000219	0.0286	CrCbGaD
Droperidol—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.000219	0.000769	CcSEcCtD
Droperidol—Anxiety—Topiramate—epilepsy syndrome	0.000215	0.000757	CcSEcCtD
Droperidol—Body temperature increased—Pregabalin—epilepsy syndrome	0.000212	0.000746	CcSEcCtD
Droperidol—Domperidone—ABCB1—epilepsy syndrome	0.000205	0.0268	CrCbGaD
Droperidol—Shock—Topiramate—epilepsy syndrome	0.000204	0.000716	CcSEcCtD
Droperidol—Tachycardia—Topiramate—epilepsy syndrome	0.000202	0.00071	CcSEcCtD
Droperidol—Hypersensitivity—Pregabalin—epilepsy syndrome	0.000198	0.000695	CcSEcCtD
Droperidol—Dizziness—Valproic Acid—epilepsy syndrome	0.000196	0.00069	CcSEcCtD
Droperidol—Body temperature increased—Gabapentin—epilepsy syndrome	0.000194	0.000684	CcSEcCtD
Droperidol—Hypotension—Topiramate—epilepsy syndrome	0.000193	0.00068	CcSEcCtD
Droperidol—Rash—Valproic Acid—epilepsy syndrome	0.000187	0.000658	CcSEcCtD
Droperidol—Dermatitis—Valproic Acid—epilepsy syndrome	0.000187	0.000657	CcSEcCtD
Droperidol—Somnolence—Topiramate—epilepsy syndrome	0.000184	0.000647	CcSEcCtD
Droperidol—Hypersensitivity—Gabapentin—epilepsy syndrome	0.000181	0.000637	CcSEcCtD
Droperidol—Dizziness—Pregabalin—epilepsy syndrome	0.000177	0.000624	CcSEcCtD
Droperidol—Pimozide—ABCB1—epilepsy syndrome	0.000171	0.0223	CrCbGaD
Droperidol—Rash—Pregabalin—epilepsy syndrome	0.000169	0.000595	CcSEcCtD
Droperidol—Dermatitis—Pregabalin—epilepsy syndrome	0.000169	0.000594	CcSEcCtD
Droperidol—Body temperature increased—Topiramate—epilepsy syndrome	0.000164	0.000575	CcSEcCtD
Droperidol—Dizziness—Gabapentin—epilepsy syndrome	0.000163	0.000572	CcSEcCtD
Droperidol—Haloperidol—ABCB1—epilepsy syndrome	0.000156	0.0204	CrCbGaD
Droperidol—Rash—Gabapentin—epilepsy syndrome	0.000155	0.000545	CcSEcCtD
Droperidol—Dermatitis—Gabapentin—epilepsy syndrome	0.000155	0.000545	CcSEcCtD
Droperidol—Hypersensitivity—Topiramate—epilepsy syndrome	0.000152	0.000536	CcSEcCtD
Droperidol—Dizziness—Topiramate—epilepsy syndrome	0.000137	0.000481	CcSEcCtD
Droperidol—Rash—Topiramate—epilepsy syndrome	0.00013	0.000459	CcSEcCtD
Droperidol—Dermatitis—Topiramate—epilepsy syndrome	0.00013	0.000458	CcSEcCtD
Droperidol—DRD2—Signaling by GPCR—AKT3—epilepsy syndrome	2.47e-05	0.000144	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—GRM5—epilepsy syndrome	2.46e-05	0.000143	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CASP2—epilepsy syndrome	2.46e-05	0.000143	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CHRM3—epilepsy syndrome	2.46e-05	0.000143	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—CDC42—epilepsy syndrome	2.44e-05	0.000142	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—GAL—epilepsy syndrome	2.44e-05	0.000142	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—GFAP—epilepsy syndrome	2.44e-05	0.000142	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—AKT3—epilepsy syndrome	2.43e-05	0.000142	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—HBEGF—epilepsy syndrome	2.43e-05	0.000141	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CASP2—epilepsy syndrome	2.42e-05	0.000141	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CHRM3—epilepsy syndrome	2.42e-05	0.000141	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—GRM5—epilepsy syndrome	2.42e-05	0.000141	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—AVP—epilepsy syndrome	2.41e-05	0.00014	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—CDC42—epilepsy syndrome	2.39e-05	0.000139	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—GAL—epilepsy syndrome	2.39e-05	0.000139	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—GFAP—epilepsy syndrome	2.39e-05	0.000139	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—AKT3—epilepsy syndrome	2.38e-05	0.000139	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—AVP—epilepsy syndrome	2.37e-05	0.000138	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—GRM5—epilepsy syndrome	2.37e-05	0.000138	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CASP2—epilepsy syndrome	2.37e-05	0.000138	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CHRM3—epilepsy syndrome	2.37e-05	0.000138	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CX3CR1—epilepsy syndrome	2.35e-05	0.000137	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—AVP—epilepsy syndrome	2.32e-05	0.000135	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CX3CR1—epilepsy syndrome	2.32e-05	0.000135	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CHRM2—epilepsy syndrome	2.31e-05	0.000134	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—BDKRB1—epilepsy syndrome	2.31e-05	0.000134	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CX3CL1—epilepsy syndrome	2.31e-05	0.000134	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CX3CL1—epilepsy syndrome	2.27e-05	0.000132	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CHRM2—epilepsy syndrome	2.27e-05	0.000132	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—BDKRB1—epilepsy syndrome	2.27e-05	0.000132	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CX3CR1—epilepsy syndrome	2.27e-05	0.000132	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—CDC42—epilepsy syndrome	2.26e-05	0.000131	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—GABBR1—epilepsy syndrome	2.25e-05	0.000131	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—BDKRB1—epilepsy syndrome	2.23e-05	0.000129	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CX3CL1—epilepsy syndrome	2.23e-05	0.000129	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CHRM2—epilepsy syndrome	2.23e-05	0.000129	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—CDC42—epilepsy syndrome	2.22e-05	0.000129	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—GABBR1—epilepsy syndrome	2.21e-05	0.000129	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—AVP—epilepsy syndrome	2.18e-05	0.000127	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—CDC42—epilepsy syndrome	2.17e-05	0.000126	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—GABBR1—epilepsy syndrome	2.16e-05	0.000126	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—HRH3—epilepsy syndrome	2.15e-05	0.000125	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—AVP—epilepsy syndrome	2.15e-05	0.000125	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—OPRM1—epilepsy syndrome	2.12e-05	0.000123	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—HRH3—epilepsy syndrome	2.12e-05	0.000123	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—AVP—epilepsy syndrome	2.1e-05	0.000122	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—OPRM1—epilepsy syndrome	2.09e-05	0.000121	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—HRH3—epilepsy syndrome	2.08e-05	0.000121	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—CCR5—epilepsy syndrome	2.05e-05	0.000119	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—OPRM1—epilepsy syndrome	2.04e-05	0.000119	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—CCR5—epilepsy syndrome	2.01e-05	0.000117	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CCR3—epilepsy syndrome	2e-05	0.000117	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—HTR2A—epilepsy syndrome	2e-05	0.000116	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—CCR5—epilepsy syndrome	1.97e-05	0.000115	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CCR3—epilepsy syndrome	1.97e-05	0.000115	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—NPY—epilepsy syndrome	1.95e-05	0.000114	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—ATP2A2—epilepsy syndrome	1.95e-05	0.000114	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CCR3—epilepsy syndrome	1.93e-05	0.000112	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.93e-05	0.000112	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—ATP2A2—epilepsy syndrome	1.92e-05	0.000112	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—NPY—epilepsy syndrome	1.92e-05	0.000112	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—AGT—epilepsy syndrome	1.9e-05	0.000111	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—HSPB1—epilepsy syndrome	1.88e-05	0.00011	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CRH—epilepsy syndrome	1.88e-05	0.00011	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—OXT—epilepsy syndrome	1.88e-05	0.00011	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CCL3—epilepsy syndrome	1.88e-05	0.00011	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CXCL2—epilepsy syndrome	1.88e-05	0.00011	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—NPY—epilepsy syndrome	1.88e-05	0.000109	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—ATP2A2—epilepsy syndrome	1.88e-05	0.000109	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—AGT—epilepsy syndrome	1.87e-05	0.000109	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—CCR5—epilepsy syndrome	1.86e-05	0.000108	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CXCL2—epilepsy syndrome	1.85e-05	0.000108	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—HSPB1—epilepsy syndrome	1.85e-05	0.000108	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—OXT—epilepsy syndrome	1.85e-05	0.000108	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CRH—epilepsy syndrome	1.85e-05	0.000108	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CCL3—epilepsy syndrome	1.85e-05	0.000108	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—AGT—epilepsy syndrome	1.83e-05	0.000106	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—CCR5—epilepsy syndrome	1.83e-05	0.000106	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—HTR2A—epilepsy syndrome	1.82e-05	0.000106	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CCL3—epilepsy syndrome	1.81e-05	0.000106	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—OXT—epilepsy syndrome	1.81e-05	0.000106	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CXCL2—epilepsy syndrome	1.81e-05	0.000106	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CRH—epilepsy syndrome	1.81e-05	0.000106	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—HSPB1—epilepsy syndrome	1.81e-05	0.000106	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—CCR5—epilepsy syndrome	1.79e-05	0.000104	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.75e-05	0.000102	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—HTR2A—epilepsy syndrome	1.75e-05	0.000102	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—TSC1—epilepsy syndrome	1.75e-05	0.000102	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PTK2B—epilepsy syndrome	1.75e-05	0.000102	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.73e-05	0.0001	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—AGT—epilepsy syndrome	1.72e-05	0.0001	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—TSC1—epilepsy syndrome	1.72e-05	0.0001	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PTK2B—epilepsy syndrome	1.72e-05	0.0001	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—NTRK2—epilepsy syndrome	1.7e-05	9.91e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—SST—epilepsy syndrome	1.7e-05	9.91e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CCR2—epilepsy syndrome	1.7e-05	9.91e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—AGT—epilepsy syndrome	1.7e-05	9.87e-05	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.69e-05	9.84e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—DUSP6—epilepsy syndrome	1.69e-05	9.82e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—TSC1—epilepsy syndrome	1.69e-05	9.81e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PTK2B—epilepsy syndrome	1.69e-05	9.81e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CCR2—epilepsy syndrome	1.68e-05	9.75e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—SST—epilepsy syndrome	1.68e-05	9.75e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—NTRK2—epilepsy syndrome	1.68e-05	9.75e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—ADRA2A—epilepsy syndrome	1.67e-05	9.7e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—AGT—epilepsy syndrome	1.66e-05	9.67e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—DUSP6—epilepsy syndrome	1.66e-05	9.66e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PLAT—epilepsy syndrome	1.66e-05	9.66e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—NTRK2—epilepsy syndrome	1.64e-05	9.55e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CCR2—epilepsy syndrome	1.64e-05	9.55e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—SST—epilepsy syndrome	1.64e-05	9.55e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—ADRA2A—epilepsy syndrome	1.64e-05	9.54e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PLAT—epilepsy syndrome	1.63e-05	9.5e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—DUSP6—epilepsy syndrome	1.63e-05	9.46e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—ADRA2A—epilepsy syndrome	1.61e-05	9.34e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CXCL12—epilepsy syndrome	1.6e-05	9.32e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—BDKRB2—epilepsy syndrome	1.6e-05	9.32e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PLAT—epilepsy syndrome	1.6e-05	9.3e-05	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—POMC—epilepsy syndrome	1.6e-05	9.3e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—PRKCB—epilepsy syndrome	1.59e-05	9.27e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—IL6ST—epilepsy syndrome	1.59e-05	9.24e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CXCL12—epilepsy syndrome	1.58e-05	9.17e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—BDKRB2—epilepsy syndrome	1.58e-05	9.17e-05	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—POMC—epilepsy syndrome	1.57e-05	9.15e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—JUNB—epilepsy syndrome	1.57e-05	9.14e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CNR1—epilepsy syndrome	1.57e-05	9.14e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—PRKCB—epilepsy syndrome	1.57e-05	9.12e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PLCB1—epilepsy syndrome	1.57e-05	9.11e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—IL6ST—epilepsy syndrome	1.56e-05	9.09e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—JUNB—epilepsy syndrome	1.55e-05	9e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CNR1—epilepsy syndrome	1.55e-05	9e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—BDKRB2—epilepsy syndrome	1.54e-05	8.97e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CXCL12—epilepsy syndrome	1.54e-05	8.97e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PLCB1—epilepsy syndrome	1.54e-05	8.96e-05	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—POMC—epilepsy syndrome	1.54e-05	8.96e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—PRKCB—epilepsy syndrome	1.54e-05	8.93e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—HTR7—epilepsy syndrome	1.53e-05	8.92e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—IL6ST—epilepsy syndrome	1.53e-05	8.9e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—JUNB—epilepsy syndrome	1.51e-05	8.81e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CNR1—epilepsy syndrome	1.51e-05	8.81e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PLCB1—epilepsy syndrome	1.51e-05	8.78e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—HTR7—epilepsy syndrome	1.51e-05	8.78e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—HBEGF—epilepsy syndrome	1.49e-05	8.66e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—HTR7—epilepsy syndrome	1.48e-05	8.59e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—HBEGF—epilepsy syndrome	1.46e-05	8.52e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—AKT3—epilepsy syndrome	1.46e-05	8.5e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—POMC—epilepsy syndrome	1.45e-05	8.45e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—AKT3—epilepsy syndrome	1.44e-05	8.36e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—HBEGF—epilepsy syndrome	1.43e-05	8.34e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—POMC—epilepsy syndrome	1.43e-05	8.31e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—ADAM10—epilepsy syndrome	1.43e-05	8.3e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—CCL2—epilepsy syndrome	1.42e-05	8.26e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—AKT3—epilepsy syndrome	1.41e-05	8.19e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—ADAM10—epilepsy syndrome	1.4e-05	8.17e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—POMC—epilepsy syndrome	1.4e-05	8.14e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—CCL2—epilepsy syndrome	1.4e-05	8.13e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—ADAM10—epilepsy syndrome	1.37e-05	8e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—CCL2—epilepsy syndrome	1.37e-05	7.96e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—S100B—epilepsy syndrome	1.35e-05	7.85e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—SOCS3—epilepsy syndrome	1.34e-05	7.77e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CDC42—epilepsy syndrome	1.33e-05	7.76e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—S100B—epilepsy syndrome	1.33e-05	7.73e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—SOCS3—epilepsy syndrome	1.31e-05	7.65e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CDC42—epilepsy syndrome	1.31e-05	7.63e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—S100B—epilepsy syndrome	1.3e-05	7.56e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—AVP—epilepsy syndrome	1.29e-05	7.51e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—SOCS3—epilepsy syndrome	1.29e-05	7.49e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CDC42—epilepsy syndrome	1.28e-05	7.47e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—AVP—epilepsy syndrome	1.27e-05	7.39e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—AVP—epilepsy syndrome	1.24e-05	7.23e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—HES1—epilepsy syndrome	1.22e-05	7.1e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—HES1—epilepsy syndrome	1.2e-05	6.99e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—FYN—epilepsy syndrome	1.19e-05	6.9e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—H2AFX—epilepsy syndrome	1.18e-05	6.88e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—MEF2C—epilepsy syndrome	1.18e-05	6.87e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—HES1—epilepsy syndrome	1.18e-05	6.84e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—FYN—epilepsy syndrome	1.17e-05	6.79e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—H2AFX—epilepsy syndrome	1.16e-05	6.77e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—MEF2C—epilepsy syndrome	1.16e-05	6.76e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—FYN—epilepsy syndrome	1.14e-05	6.65e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—YWHAZ—epilepsy syndrome	1.14e-05	6.64e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—H2AFX—epilepsy syndrome	1.14e-05	6.63e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—MEF2C—epilepsy syndrome	1.14e-05	6.62e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—NGF—epilepsy syndrome	1.13e-05	6.56e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—YWHAZ—epilepsy syndrome	1.12e-05	6.53e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—NGF—epilepsy syndrome	1.11e-05	6.46e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—YWHAZ—epilepsy syndrome	1.1e-05	6.4e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CCR5—epilepsy syndrome	1.1e-05	6.38e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—NGF—epilepsy syndrome	1.09e-05	6.32e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CCR5—epilepsy syndrome	1.08e-05	6.28e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—HTR2A—epilepsy syndrome	1.07e-05	6.25e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CCR5—epilepsy syndrome	1.06e-05	6.15e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—HTR2A—epilepsy syndrome	1.03e-05	6.02e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—TSC2—epilepsy syndrome	1.02e-05	5.94e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—AGT—epilepsy syndrome	1.02e-05	5.93e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—TSC2—epilepsy syndrome	1e-05	5.84e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—AGT—epilepsy syndrome	1e-05	5.83e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—APOE—epilepsy syndrome	9.98e-06	5.81e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—TSC2—epilepsy syndrome	9.83e-06	5.72e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—APOE—epilepsy syndrome	9.82e-06	5.72e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—AGT—epilepsy syndrome	9.81e-06	5.71e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—KDR—epilepsy syndrome	9.78e-06	5.69e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—KDR—epilepsy syndrome	9.62e-06	5.6e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—APOE—epilepsy syndrome	9.62e-06	5.6e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—KDR—epilepsy syndrome	9.42e-06	5.48e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PRKCB—epilepsy syndrome	9.41e-06	5.48e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—IL6ST—epilepsy syndrome	9.38e-06	5.46e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PRKCB—epilepsy syndrome	9.26e-06	5.39e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—IL6ST—epilepsy syndrome	9.22e-06	5.37e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PRKCB—epilepsy syndrome	9.07e-06	5.28e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—IL6ST—epilepsy syndrome	9.03e-06	5.26e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—POMC—epilepsy syndrome	8.57e-06	4.99e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—POMC—epilepsy syndrome	8.44e-06	4.91e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CCL2—epilepsy syndrome	8.39e-06	4.88e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—POMC—epilepsy syndrome	8.26e-06	4.81e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CCL2—epilepsy syndrome	8.26e-06	4.8e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CCL2—epilepsy syndrome	8.08e-06	4.7e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—FGF2—epilepsy syndrome	7.58e-06	4.41e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—FGF2—epilepsy syndrome	7.46e-06	4.34e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—FGF2—epilepsy syndrome	7.31e-06	4.25e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—RELA—epilepsy syndrome	7.04e-06	4.1e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—RELA—epilepsy syndrome	6.93e-06	4.03e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—MTOR—epilepsy syndrome	6.9e-06	4.02e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—MTOR—epilepsy syndrome	6.79e-06	3.95e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—RELA—epilepsy syndrome	6.78e-06	3.95e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—MTOR—epilepsy syndrome	6.65e-06	3.87e-05	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—AKT1—epilepsy syndrome	6.41e-06	3.73e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CASP3—epilepsy syndrome	6.35e-06	3.69e-05	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—AKT1—epilepsy syndrome	6.3e-06	3.67e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CASP3—epilepsy syndrome	6.25e-06	3.64e-05	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—AKT1—epilepsy syndrome	6.17e-06	3.59e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—JUN—epilepsy syndrome	6.17e-06	3.59e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CASP3—epilepsy syndrome	6.12e-06	3.56e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—JUN—epilepsy syndrome	6.07e-06	3.53e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—MMP9—epilepsy syndrome	6e-06	3.49e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—JUN—epilepsy syndrome	5.94e-06	3.46e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—MMP9—epilepsy syndrome	5.9e-06	3.44e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—AKT1—epilepsy syndrome	5.82e-06	3.39e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—MMP9—epilepsy syndrome	5.78e-06	3.36e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—AKT1—epilepsy syndrome	5.73e-06	3.33e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—AKT1—epilepsy syndrome	5.61e-06	3.26e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—SRC—epilepsy syndrome	5.53e-06	3.22e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—SRC—epilepsy syndrome	5.44e-06	3.17e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—VEGFA—epilepsy syndrome	5.39e-06	3.14e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—SRC—epilepsy syndrome	5.33e-06	3.1e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—VEGFA—epilepsy syndrome	5.3e-06	3.08e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—VEGFA—epilepsy syndrome	5.19e-06	3.02e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—AKT1—epilepsy syndrome	3.44e-06	2e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—AKT1—epilepsy syndrome	3.38e-06	1.97e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—AKT1—epilepsy syndrome	3.31e-06	1.93e-05	CbGpPWpGaD
